以 HPO 交叉檢視

HPO → 對應的病歷用詞，並附加具此 HPO 的疾病作為參考。

搜尋 HPO

Fatigue

HP:0012378

對應病歷用詞(0)

尚無對應用詞。

具此 HPO 的疾病（附加參考）(310)

AcromegalyORPHA:963 · Very frequent (99-80%)
Acute adrenal insufficiencyORPHA:95409 · Very frequent (99-80%)
Addison diseaseORPHA:85138 · Very frequent (99-80%)
Adiposis dolorosaORPHA:36397 · Very frequent (99-80%)
Adult-onset Still diseaseORPHA:829 · Very frequent (99-80%)
AL amyloidosisORPHA:85443 · Very frequent (99-80%)
Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16ORPHA:98791 · Very frequent (99-80%)
Alpha-thalassemia-myelodysplastic syndromeORPHA:231401 · Very frequent (99-80%)
AthyreosisORPHA:95713 · Very frequent (99-80%)
Autoimmune hemolytic anemia, warm typeORPHA:90033 · Very frequent (99-80%)
Autosomal non-syndromic agammaglobulinemiaORPHA:33110 · Very frequent (99-80%)
Avian influenzaORPHA:454836 · Very frequent (99-80%)
Behçet diseaseORPHA:117 · Very frequent (99-80%)
Benign recurrent intrahepatic cholestasisORPHA:65682 · Very frequent (99-80%)
BotulismORPHA:1267 · Very frequent (99-80%)
Brain dopamine-serotonin vesicular transport diseaseORPHA:352649 · Very frequent (99-80%)
Carney triadORPHA:139411 · Very frequent (99-80%)
Carnitine palmitoyl transferase 1A deficiencyORPHA:156 · Very frequent (99-80%)
ChikungunyaORPHA:324625 · Very frequent (99-80%)
Cholestasis-lymphedema syndromeORPHA:1414 · Very frequent (99-80%)
CINCA syndromeORPHA:1451 · Very frequent (99-80%)
Classic Hodgkin lymphomaORPHA:391 · Very frequent (99-80%)
Cold agglutinin diseaseORPHA:56425 · Very frequent (99-80%)
Congenital hyperinsulinism due to HNF4A deficiencyORPHA:263455 · Very frequent (99-80%)
Congenital isolated ACTH deficiencyORPHA:199296 · Very frequent (99-80%)
CystinosisORPHA:213 · Very frequent (99-80%)
Deficiency in anterior pituitary function-variable immunodeficiency syndromeORPHA:293978 · Very frequent (99-80%)
Drug-induced autoimmune hemolytic anemiaORPHA:90037 · Very frequent (99-80%)
Ebstein malformation of the tricuspid valveORPHA:1880 · Very frequent (99-80%)
Eosinophilic fasciitisORPHA:3165 · Very frequent (99-80%)
Erdheim-Chester diseaseORPHA:35687 · Very frequent (99-80%)
Essential thrombocythemiaORPHA:3318 · Very frequent (99-80%)
Fabry diseaseORPHA:324 · Very frequent (99-80%)
Familial cold urticariaORPHA:47045 · Very frequent (99-80%)
Familial colorectal cancer Type XORPHA:440437 · Very frequent (99-80%)
Gamma-heavy chain diseaseORPHA:100026 · Very frequent (99-80%)
GATA2 deficiency spectrumORPHA:228423 · Very frequent (99-80%)
Gaucher diseaseORPHA:355 · Very frequent (99-80%)
Gaucher disease type 3ORPHA:77261 · Very frequent (99-80%)
Generalized glucocorticoid resistance syndromeORPHA:786 · Very frequent (99-80%)
Giant cell arteritisORPHA:397 · Very frequent (99-80%)
Granulomatosis with polyangiitisORPHA:900 · Very frequent (99-80%)
Hughes-Stovin syndromeORPHA:228116 · Very frequent (99-80%)
Hypermobile Ehlers-Danlos syndromeORPHA:285 · Very frequent (99-80%)
Iatrogenic botulismORPHA:254509 · Very frequent (99-80%)
Infection-related hemolytic uremic syndromeORPHA:544482 · Very frequent (99-80%)
Inhalational anthraxORPHA:247257 · Very frequent (99-80%)
Inhalational botulismORPHA:254504 · Very frequent (99-80%)
Juvenile dermatomyositisORPHA:93672 · Very frequent (99-80%)
Late-onset isolated ACTH deficiencyORPHA:199299 · Very frequent (99-80%)
Legionnaires diseaseORPHA:549 · Very frequent (99-80%)
Lynch syndromeORPHA:144 · Very frequent (99-80%)
Macrophagic myofasciitisORPHA:592 · Very frequent (99-80%)
MALT lymphomaORPHA:52417 · Very frequent (99-80%)
Menkes diseaseORPHA:565 · Very frequent (99-80%)
Methylmalonic acidemia with homocystinuriaORPHA:26 · Very frequent (99-80%)
Methylmalonic acidemia with homocystinuria, type cblDORPHA:79283 · Very frequent (99-80%)
Mixed connective tissue diseaseORPHA:809 · Very frequent (99-80%)
Mixed-type autoimmune hemolytic anemiaORPHA:90036 · Very frequent (99-80%)
Myelodysplastic neoplasm with increased blastsORPHA:86839 · Very frequent (99-80%)
Nipah virus diseaseORPHA:99825 · Very frequent (99-80%)
Non-insulinoma pancreatogenous hypoglycemia syndromeORPHA:276608 · Very frequent (99-80%)
Non-syndromic agammaglobulinemiaORPHA:229717 · Very frequent (99-80%)
Oculopharyngeal muscular dystrophyORPHA:270 · Very frequent (99-80%)
PAPA syndromeORPHA:69126 · Very frequent (99-80%)
PlagueORPHA:707 · Very frequent (99-80%)
Pontiac feverORPHA:99748 · Very frequent (99-80%)
Postorgasmic illness syndromeORPHA:279947 · Very frequent (99-80%)
Primary familial and congenital erythrocytosisORPHA:90042 · Very frequent (99-80%)
Reynolds syndromeORPHA:779 · Very frequent (99-80%)
SomatomammotropinomaORPHA:314769 · Very frequent (99-80%)
Spontaneous periodic hypothermiaORPHA:29822 · Very frequent (99-80%)
Stevens-Johnson syndromeORPHA:36426 · Very frequent (99-80%)
Stevens-Johnson syndrome/toxic epidermal necrolysis spectrumORPHA:95455 · Very frequent (99-80%)
Systemic lupus erythematosusORPHA:536 · Very frequent (99-80%)
T-cell based immunotherapy-associated cytokine release syndromeORPHA:542323 · Very frequent (99-80%)
Takayasu arteritisORPHA:3287 · Very frequent (99-80%)
Thyroid hemiagenesisORPHA:95719 · Very frequent (99-80%)
Thyroid hypoplasiaORPHA:95720 · Very frequent (99-80%)
Toxic epidermal necrolysisORPHA:537 · Very frequent (99-80%)
Tropical endomyocardial fibrosisORPHA:75565 · Very frequent (99-80%)
TyphoidORPHA:99745 · Very frequent (99-80%)
Whipple diseaseORPHA:3452 · Very frequent (99-80%)
X-linked agammaglobulinemiaORPHA:47 · Very frequent (99-80%)
X-linked sideroblastic anemiaORPHA:75563 · Very frequent (99-80%)
Xeroderma pigmentosumORPHA:910 · Very frequent (99-80%)
Acquired methemoglobinemiaORPHA:464453 · Frequent (79-30%)
Acute interstitial pneumoniaORPHA:79126 · Frequent (79-30%)
Acute monoblastic/monocytic leukemiaORPHA:514 · Frequent (79-30%)
Acute panmyelosis with myelofibrosisORPHA:86843 · Frequent (79-30%)
Acute promyelocytic leukemiaORPHA:520 · Frequent (79-30%)
AdrenomyeloneuropathyORPHA:139399 · Frequent (79-30%)
African trypanosomiasisORPHA:3385 · Frequent (79-30%)
Aggressive systemic mastocytosisORPHA:98850 · Frequent (79-30%)
Albers-Schönberg osteopetrosisORPHA:53 · Frequent (79-30%)
Alveolar echinococcosisORPHA:284 · Frequent (79-30%)
Amyotrophic lateral sclerosisORPHA:803 · Frequent (79-30%)
AngiostrongyliasisORPHA:74 · Frequent (79-30%)
Antiphospholipid syndromeORPHA:80 · Frequent (79-30%)
Arterial tortuosity syndromeORPHA:3342 · Frequent (79-30%)
Atrial septal defect, coronary sinus typeORPHA:99104 · Frequent (79-30%)
Atrial septal defect, ostium primum typeORPHA:99106 · Frequent (79-30%)
Atrial septal defect, ostium secundum typeORPHA:99103 · Frequent (79-30%)
Atrial septal defect, sinus venosus typeORPHA:99105 · Frequent (79-30%)
Atypical juvenile parkinsonismORPHA:391411 · Frequent (79-30%)
Autosomal dominant adult-onset proximal spinal muscular atrophyORPHA:209335 · Frequent (79-30%)
Autosomal dominant Charcot-Marie-Tooth disease type 2ZORPHA:466768 · Frequent (79-30%)
Autosomal dominant dopa-responsive dystoniaORPHA:98808 · Frequent (79-30%)
Autosomal dominant hypophosphatemic ricketsORPHA:89937 · Frequent (79-30%)
Autosomal dominant optic atrophy plus syndromeORPHA:1215 · Frequent (79-30%)
Autosomal dominant progressive external ophthalmoplegiaORPHA:254892 · Frequent (79-30%)
BabesiosisORPHA:108 · Frequent (79-30%)
Becker muscular dystrophyORPHA:98895 · Frequent (79-30%)
BrucellosisORPHA:1304 · Frequent (79-30%)
Castleman diseaseORPHA:160 · Frequent (79-30%)
CholangiocarcinomaORPHA:70567 · Frequent (79-30%)
Chronic beryllium diseaseORPHA:133 · Frequent (79-30%)
Chronic myeloid leukemiaORPHA:521 · Frequent (79-30%)
Chronic nonbacterial osteomyelitis/Chronic recurrent multifocal osteomyelitisORPHA:324964 · Frequent (79-30%)
Chronic thromboembolic pulmonary hypertensionORPHA:70591 · Frequent (79-30%)
Classical Ehlers-Danlos syndromeORPHA:287 · Frequent (79-30%)
Classical-like Ehlers-Danlos syndrome type 1ORPHA:230839 · Frequent (79-30%)
Combined pituitary hormone deficiencies, genetic formsORPHA:95494 · Frequent (79-30%)
Congenital analbuminemiaORPHA:86816 · Frequent (79-30%)
Congenital dyserythropoietic anemia type IIIORPHA:98870 · Frequent (79-30%)
Congenital fiber-type disproportion myopathyORPHA:2020 · Frequent (79-30%)
Congenital Gerbode defectORPHA:99095 · Frequent (79-30%)
Congenital glucokinase-related hyperinsulinismORPHA:79299 · Frequent (79-30%)
Congenital total pulmonary venous return anomalyORPHA:99125 · Frequent (79-30%)
Cronkhite-Canada syndromeORPHA:2930 · Frequent (79-30%)
Cryptogenic organizing pneumoniaORPHA:1302 · Frequent (79-30%)
Cyclic neutropeniaORPHA:2686 · Frequent (79-30%)
Cystic echinococcosisORPHA:400 · Frequent (79-30%)
Cytomegalovirus disease in patients with impaired cell mediated immunity deemed at riskORPHA:137698 · Frequent (79-30%)
DermatomyositisORPHA:221 · Frequent (79-30%)
Dopamine beta-hydroxylase deficiencyORPHA:230 · Frequent (79-30%)
Eisenmenger syndromeORPHA:97214 · Frequent (79-30%)
Eosinophilic granulomatosis with polyangiitisORPHA:183 · Frequent (79-30%)
Evans syndromeORPHA:1959 · Frequent (79-30%)
Exercise-induced malignant hyperthermiaORPHA:466650 · Frequent (79-30%)
Familial isolated dilated cardiomyopathyORPHA:154 · Frequent (79-30%)
Familial Mediterranean feverORPHA:342 · Frequent (79-30%)
Follicular lymphomaORPHA:545 · Frequent (79-30%)
Functioning gonadotropic adenomaORPHA:91348 · Frequent (79-30%)
Gastrointestinal stromal tumorORPHA:44890 · Frequent (79-30%)
Generalized pustular psoriasisORPHA:247353 · Frequent (79-30%)
GlioblastomaORPHA:360 · Frequent (79-30%)
Glycogen storage disease due to acid maltase deficiencyORPHA:365 · Frequent (79-30%)
Glycogen storage disease due to muscle phosphorylase kinase deficiencyORPHA:715 · Frequent (79-30%)
HELLP syndromeORPHA:244242 · Frequent (79-30%)
Hemorrhagic fever-renal syndromeORPHA:340 · Frequent (79-30%)
Hereditary atrial fibrillationORPHA:334 · Frequent (79-30%)
Hereditary pheochromocytoma-paragangliomaORPHA:29072 · Frequent (79-30%)
Herpes simplex virus encephalitisORPHA:1930 · Frequent (79-30%)
Hyperinsulinism due to INSR deficiencyORPHA:263458 · Frequent (79-30%)
Hyperparathyroidism-jaw tumor syndromeORPHA:99880 · Frequent (79-30%)
HypophosphatasiaORPHA:436 · Frequent (79-30%)
Hypothyroidism due to deficient transcription factors involved in pituitary development or functionORPHA:226307 · Frequent (79-30%)
Hypotonia-cystinuria syndromeORPHA:163690 · Frequent (79-30%)
Idiopathic pulmonary fibrosisORPHA:2032 · Frequent (79-30%)
Idiopathic pulmonary hemosiderosisORPHA:99931 · Frequent (79-30%)
Idiopathic steroid-sensitive nephrotic syndrome with secondary steroid resistanceORPHA:567546 · Frequent (79-30%)
IgG4-related retroperitoneal fibrosisORPHA:49041 · Frequent (79-30%)
Immune-mediated thrombotic thrombocytopenic purpuraORPHA:93585 · Frequent (79-30%)
Insulin-resistance syndrome type BORPHA:2298 · Frequent (79-30%)
Isolated atrial standstillORPHA:1344 · Frequent (79-30%)
Isolated right ventricular hypoplasiaORPHA:439 · Frequent (79-30%)
Isolated thyroid-stimulating hormone deficiencyORPHA:90674 · Frequent (79-30%)
Japanese encephalitisORPHA:79139 · Frequent (79-30%)
Kawasaki diseaseORPHA:2331 · Frequent (79-30%)
Kikuchi-Fujimoto diseaseORPHA:50918 · Frequent (79-30%)
Kufor-Rakeb syndromeORPHA:306674 · Frequent (79-30%)
Laubry-Pezzi syndromeORPHA:99094 · Frequent (79-30%)
Lead poisoningORPHA:330015 · Frequent (79-30%)
Liddle syndromeORPHA:526 · Frequent (79-30%)
ListeriosisORPHA:533 · Frequent (79-30%)
Loeffler endocarditisORPHA:75566 · Frequent (79-30%)
Lymphatic filariasisORPHA:2035 · Frequent (79-30%)
Lymphoid interstitial pneumoniaORPHA:79128 · Frequent (79-30%)
Malignant atrophic papulosisORPHA:679 · Frequent (79-30%)
Mantle cell lymphomaORPHA:52416 · Frequent (79-30%)
Mast cell sarcomaORPHA:66661 · Frequent (79-30%)
Microscopic polyangiitisORPHA:727 · Frequent (79-30%)
Multiple myelomaORPHA:29073 · Frequent (79-30%)
Myasthenia gravisORPHA:589 · Frequent (79-30%)
Myelodysplastic neoplasm with low blastsORPHA:98826 · Frequent (79-30%)
MYT1L-related developmental delay-intellectual disability-obesity syndromeORPHA:647799 · Frequent (79-30%)
Necrotizing enterocolitisORPHA:391673 · Frequent (79-30%)
NeuroblastomaORPHA:635 · Frequent (79-30%)
Neuroleptic malignant syndromeORPHA:94093 · Frequent (79-30%)
NocardiosisORPHA:31204 · Frequent (79-30%)
Non-acquired panhypopituitarismORPHA:90695 · Frequent (79-30%)
Non-functioning paragangliomaORPHA:94080 · Frequent (79-30%)
Non-functioning pituitary adenomaORPHA:91349 · Frequent (79-30%)
Osteogenesis imperfectaORPHA:666 · Frequent (79-30%)
Pancreatic triacylglycerol lipase deficiencyORPHA:309031 · Frequent (79-30%)
Parathyroid carcinomaORPHA:143 · Frequent (79-30%)
Pediatric hepatocellular carcinomaORPHA:33402 · Frequent (79-30%)
PellagraORPHA:97352 · Frequent (79-30%)
Peripartum cardiomyopathyORPHA:563 · Frequent (79-30%)
PFAPA syndromeORPHA:42642 · Frequent (79-30%)
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndromeORPHA:589905 · Frequent (79-30%)
POEMS syndromeORPHA:2905 · Frequent (79-30%)
PoliomyelitisORPHA:2912 · Frequent (79-30%)
Polycythemia veraORPHA:729 · Frequent (79-30%)
PolymyositisORPHA:732 · Frequent (79-30%)
Post-transplant lymphoproliferative diseaseORPHA:70568 · Frequent (79-30%)
Postpoliomyelitis syndromeORPHA:2942 · Frequent (79-30%)
Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndromeORPHA:562639 · Frequent (79-30%)
Primary myelofibrosisORPHA:824 · Frequent (79-30%)
Primary Sjögren diseaseORPHA:289390 · Frequent (79-30%)
ProlactinomaORPHA:2965 · Frequent (79-30%)
Proximal spinal muscular atrophyORPHA:70 · Frequent (79-30%)
Pulmonary alveolar microlithiasisORPHA:60025 · Frequent (79-30%)
Pulmonary non-tuberculous mycobacterial infectionORPHA:411703 · Frequent (79-30%)
Q feverORPHA:781 · Frequent (79-30%)
Resistance to thyrotropin-releasing hormone syndromeORPHA:99832 · Frequent (79-30%)
Rheumatic feverORPHA:3099 · Frequent (79-30%)
SarcoidosisORPHA:797 · Frequent (79-30%)
Schnitzler syndromeORPHA:37748 · Frequent (79-30%)
Secondary hypoparathyroidism due to impaired parathormon secretionORPHA:140286 · Frequent (79-30%)
Secondary intestinal lymphangiectasiaORPHA:90363 · Frequent (79-30%)
Severe congenital hypochromic anemia with ringed sideroblastsORPHA:300298 · Frequent (79-30%)
ShigellosisORPHA:810 · Frequent (79-30%)
Simple cryoglobulinemiaORPHA:91139 · Frequent (79-30%)
Southeast Asian ovalocytosisORPHA:98868 · Frequent (79-30%)
Spinal arteriovenous metameric syndromeORPHA:53721 · Frequent (79-30%)
Sporadic pheochromocytoma/secreting paragangliomaORPHA:276621 · Frequent (79-30%)
Steinert myotonic dystrophyORPHA:273 · Frequent (79-30%)
Subcutaneous panniculitis-like T-cell lymphomaORPHA:86884 · Frequent (79-30%)
Symptomatic form of HFE-related hemochromatosisORPHA:465508 · Frequent (79-30%)
Systemic capillary leak syndromeORPHA:188 · Frequent (79-30%)
Systemic mastocytosis with associated hematologic neoplasmORPHA:98849 · Frequent (79-30%)
Thyroid ectopiaORPHA:95712 · Frequent (79-30%)
Tick-borne encephalitisORPHA:297 · Frequent (79-30%)
TSH-secreting pituitary adenomaORPHA:91347 · Frequent (79-30%)
Tubulointerstitial nephritis and uveitis syndromeORPHA:91500 · Frequent (79-30%)
Unclassified myelodysplastic syndromeORPHA:98827 · Frequent (79-30%)
Usher syndrome type 2ORPHA:231178 · Frequent (79-30%)
Visual snow syndromeORPHA:420556 · Frequent (79-30%)
Wiskott-Aldrich syndromeORPHA:906 · Frequent (79-30%)
X-linked adrenal hypoplasia congenitaORPHA:95702 · Frequent (79-30%)
ZygomycosisORPHA:73263 · Frequent (79-30%)
3-hydroxy-3-methylglutaric aciduriaORPHA:20 · Occasional (29-5%)
Acute radiation syndromeORPHA:454831 · Occasional (29-5%)
Acute transverse myelitisORPHA:139417 · Occasional (29-5%)
ArachnoiditisORPHA:137817 · Occasional (29-5%)
Autoerythrocyte sensitization syndromeORPHA:324636 · Occasional (29-5%)
Autosomal dominant spastic paraplegia type 37ORPHA:171612 · Occasional (29-5%)
Cardiac-valvular Ehlers-Danlos syndromeORPHA:230851 · Occasional (29-5%)
CLN12 diseaseORPHA:314632 · Occasional (29-5%)
CoccidioidomycosisORPHA:228123 · Occasional (29-5%)
Congenital heart blockORPHA:60041 · Occasional (29-5%)
Congenital sucrase-isomaltase deficiencyORPHA:35122 · Occasional (29-5%)
Cutaneous mastocytosis-deafness-microtia syndromeORPHA:2135 · Occasional (29-5%)
Dermatosparaxis Ehlers-Danlos syndromeORPHA:1901 · Occasional (29-5%)
Dubin-Johnson syndromeORPHA:234 · Occasional (29-5%)
Epidermolysis bullosa simplex with muscular dystrophyORPHA:257 · Occasional (29-5%)
Familial hypocalciuric hypercalcemiaORPHA:405 · Occasional (29-5%)
Fixed drug eruptionORPHA:293812 · Occasional (29-5%)
Genetic hyperferritinemia without iron overloadORPHA:254704 · Occasional (29-5%)
Glycogen storage disease due to liver and muscle phosphorylase kinase deficiencyORPHA:79240 · Occasional (29-5%)
Glycogen storage disease due to liver phosphorylase kinase deficiencyORPHA:264580 · Occasional (29-5%)
Glycogen storage disease due to muscle glycogen phosphorylase deficiencyORPHA:368 · Occasional (29-5%)
Hepatitis deltaORPHA:402823 · Occasional (29-5%)
Hereditary angioedema with C1Inh deficiencyORPHA:528623 · Occasional (29-5%)
Hereditary ATTR amyloidosisORPHA:271861 · Occasional (29-5%)
Hereditary elliptocytosisORPHA:288 · Occasional (29-5%)
Hermansky-Pudlak syndromeORPHA:79430 · Occasional (29-5%)
Hyperammonemia due to N-acetylglutamate synthase deficiencyORPHA:927 · Occasional (29-5%)
Idiopathic/heritable pulmonary arterial hypertensionORPHA:422 · Occasional (29-5%)
IgG4-related dacryoadenitis and sialadenitisORPHA:79078 · Occasional (29-5%)
IgG4-related kidney diseaseORPHA:449395 · Occasional (29-5%)
InsulinomaORPHA:97279 · Occasional (29-5%)
Interatrial communicationORPHA:1478 · Occasional (29-5%)
Kaposi sarcomaORPHA:33276 · Occasional (29-5%)
LeishmaniasisORPHA:507 · Occasional (29-5%)
LiposarcomaORPHA:69078 · Occasional (29-5%)
Lyme diseaseORPHA:91546 · Occasional (29-5%)
LymphangioleiomyomatosisORPHA:538 · Occasional (29-5%)
Mal de débarquementORPHA:210272 · Occasional (29-5%)
Medium chain acyl-CoA dehydrogenase deficiencyORPHA:42 · Occasional (29-5%)
Methotrexate toxicityORPHA:565782 · Occasional (29-5%)
Mitochondrial DNA-related cardiomyopathy and hearing lossORPHA:1349 · Occasional (29-5%)
Mucolipidosis type IIIORPHA:577 · Occasional (29-5%)
Myotonia fluctuansORPHA:99734 · Occasional (29-5%)
New-onset refractory status epilepticusORPHA:363558 · Occasional (29-5%)
Nodular lymphocyte predominant Hodgkin lymphomaORPHA:86893 · Occasional (29-5%)
Perihilar cholangiocarcinomaORPHA:99978 · Occasional (29-5%)
PituicytomaORPHA:251623 · Occasional (29-5%)
Pituitary apoplexyORPHA:95613 · Occasional (29-5%)
Post-traumatic pituitary deficiencyORPHA:95619 · Occasional (29-5%)
Primary biliary cholangitisORPHA:186 · Occasional (29-5%)
Primary sclerosing cholangitisORPHA:171 · Occasional (29-5%)
Proximal myotonic myopathyORPHA:606 · Occasional (29-5%)
Recurrent infections associated with rare immunoglobulin isotypes deficiencyORPHA:183675 · Occasional (29-5%)
Relapsing feverORPHA:91547 · Occasional (29-5%)
Renal nutcracker syndromeORPHA:71273 · Occasional (29-5%)
Septo-optic dysplasia spectrumORPHA:3157 · Occasional (29-5%)
Severe disseminated cytomegalovirus infection in immunocompetent patientsORPHA:35062 · Occasional (29-5%)
Solitary fibrous tumorORPHA:2126 · Occasional (29-5%)
Sporadic Creutzfeldt-Jakob diseaseORPHA:204 · Occasional (29-5%)
Tetrasomy 9p syndromeORPHA:3310 · Occasional (29-5%)
Thymic carcinomaORPHA:99868 · Occasional (29-5%)
Undifferentiated pleomorphic sarcomaORPHA:2023 · Occasional (29-5%)
Waldenström macroglobulinemiaORPHA:33226 · Occasional (29-5%)
X-linked hypophosphatemiaORPHA:89936 · Occasional (29-5%)
Autoimmune pulmonary alveolar proteinosisORPHA:747 · Very rare (<4-1%)
Autosomal dominant optic atrophy, classic formORPHA:98673 · Very rare (<4-1%)
Hereditary angioedema with normal C1InhORPHA:528647 · Very rare (<4-1%)